Cargando…
Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients
Introduction Coronavirus disease 2019 (COVID-19) disease attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown associations with various fungal opportunistic infections such as mucormycosis, invasive candidiasis, and aspergillosis, which have contributed to the mortali...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772619/ https://www.ncbi.nlm.nih.gov/pubmed/35103148 http://dx.doi.org/10.7759/cureus.20569 |
_version_ | 1784635884355715072 |
---|---|
author | Bhadania, Simple Bhalodiya, Neena Sethi, Yashendra Kaka, Nirja Mishra, Swati Patel, Neil Wasim, Asad Ullah Joshi, Saumya S Shah, Kenisha |
author_facet | Bhadania, Simple Bhalodiya, Neena Sethi, Yashendra Kaka, Nirja Mishra, Swati Patel, Neil Wasim, Asad Ullah Joshi, Saumya S Shah, Kenisha |
author_sort | Bhadania, Simple |
collection | PubMed |
description | Introduction Coronavirus disease 2019 (COVID-19) disease attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown associations with various fungal opportunistic infections such as mucormycosis, invasive candidiasis, and aspergillosis, which have contributed to the mortality of the disease. In India, the incidence of mucormycosis had risen rapidly during the second wave. There is ample literature demonstrating the role of iron in the pathogenesis of mucormycosis. The hyperferritinemia associated with COVID-19 may have played a significant role in promoting the invasion and extent of the fungus. Aims and objectives The study aimed to analyze the association between serum ferritin levels and the extent of involvement of mucormycosis in patients affected with COVID-19. Methodology A single-center cross-sectional study was conducted using retrospective hospital record data. G*Power statistical analysis software was used to compute the sample size of 62 (31+31). The radiological data were used to determine the extent of involvement. Results A statistically significant difference was seen in levels of serum ferritin (p = 0.008) between the radiologically judged two groups of the mild extent of invasion of mucormycosis (rhinosinusitis) and severe extent of invasion (rhino-orbital/cerebral mucormycosis), with a severe extent seen with the group having higher levels of serum ferritin. Severe extent of invasion was seen in 53.6% of patients with diabetes mellitus and 62.5% of patients with both diabetes and hypertension. Conclusion The hyperferritinemia not only presents as a marker of the systemic inflammatory process in COVID-19 but also indicates increased free iron, which thereby aids the growth and extent of involvement by the fungus (Rhizopus oryzae). In individuals with diabetes and hypertension, the severity was greater. Controlling catastrophic outcomes in individuals with high serum ferritin levels necessitates extra caution. |
format | Online Article Text |
id | pubmed-8772619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-87726192022-01-30 Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients Bhadania, Simple Bhalodiya, Neena Sethi, Yashendra Kaka, Nirja Mishra, Swati Patel, Neil Wasim, Asad Ullah Joshi, Saumya S Shah, Kenisha Cureus Internal Medicine Introduction Coronavirus disease 2019 (COVID-19) disease attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown associations with various fungal opportunistic infections such as mucormycosis, invasive candidiasis, and aspergillosis, which have contributed to the mortality of the disease. In India, the incidence of mucormycosis had risen rapidly during the second wave. There is ample literature demonstrating the role of iron in the pathogenesis of mucormycosis. The hyperferritinemia associated with COVID-19 may have played a significant role in promoting the invasion and extent of the fungus. Aims and objectives The study aimed to analyze the association between serum ferritin levels and the extent of involvement of mucormycosis in patients affected with COVID-19. Methodology A single-center cross-sectional study was conducted using retrospective hospital record data. G*Power statistical analysis software was used to compute the sample size of 62 (31+31). The radiological data were used to determine the extent of involvement. Results A statistically significant difference was seen in levels of serum ferritin (p = 0.008) between the radiologically judged two groups of the mild extent of invasion of mucormycosis (rhinosinusitis) and severe extent of invasion (rhino-orbital/cerebral mucormycosis), with a severe extent seen with the group having higher levels of serum ferritin. Severe extent of invasion was seen in 53.6% of patients with diabetes mellitus and 62.5% of patients with both diabetes and hypertension. Conclusion The hyperferritinemia not only presents as a marker of the systemic inflammatory process in COVID-19 but also indicates increased free iron, which thereby aids the growth and extent of involvement by the fungus (Rhizopus oryzae). In individuals with diabetes and hypertension, the severity was greater. Controlling catastrophic outcomes in individuals with high serum ferritin levels necessitates extra caution. Cureus 2021-12-21 /pmc/articles/PMC8772619/ /pubmed/35103148 http://dx.doi.org/10.7759/cureus.20569 Text en Copyright © 2021, Bhadania et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Bhadania, Simple Bhalodiya, Neena Sethi, Yashendra Kaka, Nirja Mishra, Swati Patel, Neil Wasim, Asad Ullah Joshi, Saumya S Shah, Kenisha Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title | Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title_full | Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title_fullStr | Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title_full_unstemmed | Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title_short | Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients |
title_sort | hyperferritinemia and the extent of mucormycosis in covid-19 patients |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772619/ https://www.ncbi.nlm.nih.gov/pubmed/35103148 http://dx.doi.org/10.7759/cureus.20569 |
work_keys_str_mv | AT bhadaniasimple hyperferritinemiaandtheextentofmucormycosisincovid19patients AT bhalodiyaneena hyperferritinemiaandtheextentofmucormycosisincovid19patients AT sethiyashendra hyperferritinemiaandtheextentofmucormycosisincovid19patients AT kakanirja hyperferritinemiaandtheextentofmucormycosisincovid19patients AT mishraswati hyperferritinemiaandtheextentofmucormycosisincovid19patients AT patelneil hyperferritinemiaandtheextentofmucormycosisincovid19patients AT wasimasadullah hyperferritinemiaandtheextentofmucormycosisincovid19patients AT joshisaumyas hyperferritinemiaandtheextentofmucormycosisincovid19patients AT shahkenisha hyperferritinemiaandtheextentofmucormycosisincovid19patients |